| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/20/2011 | US20110257146 Method of Treating Kcnq Related Disorders Using Organozinc Compounds |
| 10/20/2011 | US20110257145 Method of treating neurological diseases |
| 10/20/2011 | US20110257144 Novel dermaceutical cream made using sodium fusidate |
| 10/20/2011 | US20110257143 Compositions and Method for the Treatment of Multiple Myeloma |
| 10/20/2011 | US20110257142 Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 10/20/2011 | US20110257141 Transdermal pharmaceutical formulation for minimizing skin residues |
| 10/20/2011 | US20110257140 Biomarkers of Mineralocorticoid Receptor Activation |
| 10/20/2011 | US20110257139 Treatment of diarrhoea |
| 10/20/2011 | US20110257138 Monoterpenes for treating respiratory tract diseases, in particular bronchopulmonary diseases |
| 10/20/2011 | US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 10/20/2011 | US20110257136 Ophthalmic Formulations Of Cetirizine And Methods Of Use |
| 10/20/2011 | US20110257134 CO-CRYSTALS OF TRAMADOL AND NSAIDs |
| 10/20/2011 | US20110257133 Dosage regimen for a s1p receptor agonist |
| 10/20/2011 | US20110257132 Charged phospholipid compositions and methods for their use |
| 10/20/2011 | US20110257131 Phenylalkyl-imidazole-bisphosphonate compounds |
| 10/20/2011 | US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders |
| 10/20/2011 | US20110257129 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 10/20/2011 | US20110257127 A2b adenosine receptor antagonists |
| 10/20/2011 | US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy |
| 10/20/2011 | US20110257125 Mucomimetic compositions and uses therefore |
| 10/20/2011 | US20110257124 Esterified Polysaccharide Osmotics |
| 10/20/2011 | US20110257123 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 10/20/2011 | US20110257122 Nucleoside phosphoramidate prodrugs |
| 10/20/2011 | US20110257121 Purine nucleoside phosphoramidate |
| 10/20/2011 | US20110257120 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b |
| 10/20/2011 | US20110257119 Microcirculation improvement and/or treatment |
| 10/20/2011 | US20110257118 Vascular Circulation in Peripheral and/or Small Blood Vessels |
| 10/20/2011 | US20110257117 Olive compositions and methods for treating inflammatory conditions |
| 10/20/2011 | US20110257115 Method for treating rhinitis and sinusitis by rhamnolipids |
| 10/20/2011 | US20110257114 Crystalline forms of 1,6-bis [3-(3-carboxymethylphenyl)-4-(2-alpha-d-mannopyranosyl-oxy)-phenyl] hexane |
| 10/20/2011 | US20110257113 Method for Inducing a Trif-Bias |
| 10/20/2011 | US20110257112 Isolated compounds from phaleria macrocarpa as anti-cancer agents |
| 10/20/2011 | US20110257111 Hydroxyethlamino Sulfonamide Derivatives |
| 10/20/2011 | US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
| 10/20/2011 | US20110257109 Use of drugs that activate p2y receptors to enhance synaptogenesis |
| 10/20/2011 | US20110257107 Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria |
| 10/20/2011 | US20110257106 Polymer Stabilized Neuropeptides |
| 10/20/2011 | US20110257103 Compositions and methods for the treatment of sj?rgren's syndrome |
| 10/20/2011 | US20110257101 Catecholamine regulated protein |
| 10/20/2011 | US20110257100 Inhibitors of Protein Tyrosine Kinase Activity |
| 10/20/2011 | US20110257090 Solutions for volume therapy |
| 10/20/2011 | US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same |
| 10/20/2011 | US20110257083 Msp-1 protein preparations from plasmodium |
| 10/20/2011 | US20110257080 Hepatitis B Virus Compositions and Methods of Use |
| 10/20/2011 | US20110257078 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 10/20/2011 | US20110257075 Guanidino acetic acid used as an animal food additive |
| 10/20/2011 | US20110257074 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation |
| 10/20/2011 | US20110257011 Substituted Amidine Compounds for Combating Animal Pests |
| 10/20/2011 | US20110257009 Active Compound Combinations |
| 10/20/2011 | US20110256510 Use of Quaternary Ammonium Compounds to Inhibit Endogenous MMPs in Tooth Dentin |
| 10/20/2011 | US20110256260 Methods and compositions for synthesis of long chain polyunsaturatd fatty acids |
| 10/20/2011 | US20110256249 Hair and scalp care formulations for treating and preventing acne and related skin conditions |
| 10/20/2011 | US20110256248 Antioxidant Compositions and Methods Thereto |
| 10/20/2011 | US20110256247 Topical compositions containing nitro fatty acids |
| 10/20/2011 | US20110256240 Combination Therapy |
| 10/20/2011 | US20110256237 Methods and compositions for treating acne vulgaris and acne rosacea |
| 10/20/2011 | US20110256236 Enhancement of the Anti-Leukemic Effect of Thalidomide |
| 10/20/2011 | US20110256235 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 10/20/2011 | US20110256229 Rapid-acting pharmaceutical composition |
| 10/20/2011 | US20110256227 Controlled polyplex assembly |
| 10/20/2011 | US20110256226 Opioid agonist formulations with releasable and sequestered antagonist |
| 10/20/2011 | US20110256225 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| 10/20/2011 | US20110256224 Methods and compositions for targeted delivery |
| 10/20/2011 | US20110256223 Gastric retained gabapentin dosage form |
| 10/20/2011 | US20110256221 Pharmaceutical formulations of olmesartan |
| 10/20/2011 | US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof |
| 10/20/2011 | US20110256218 Controlled release compositions comprising meclizine or related piperazine derivatives |
| 10/20/2011 | US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 10/20/2011 | US20110256213 Phospholipid micellar and liposomal compositions and uses thereof |
| 10/20/2011 | US20110256212 Use of 8-Quinolinol and its Analogs to Target Cancer Stem Cells |
| 10/20/2011 | US20110256211 Transdermal Delivery |
| 10/20/2011 | US20110256210 Transdermal Delivery |
| 10/20/2011 | US20110256206 Implantable devices for treating hiv |
| 10/20/2011 | US20110256203 Porous ceramic scaffold having an organic/inorganic hybrid coating layer containing bioactive factor and method thereof |
| 10/20/2011 | US20110256190 Modified release compositions comprising tacrolimus |
| 10/20/2011 | US20110256188 Dry powder pharmaceutical composition for inhalation |
| 10/20/2011 | US20110256187 Biofilm-inhibitory coatings that release salicyclic acid by hydrolisis |
| 10/20/2011 | US20110256186 biomaterial based on wharton's jelly from the human umbilical cord |
| 10/20/2011 | US20110256185 Reinforced tissue shields |
| 10/20/2011 | US20110256175 Amino lipids and methods for the delivery of nucleic acids |
| 10/20/2011 | US20110256170 Method For Increasing Performance of Offspring |
| 10/20/2011 | US20110256161 Methods for enhancing immune response |
| 10/20/2011 | US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 10/20/2011 | US20110256152 Methods Of Treating And Preventing Glucose Toxicity |
| 10/20/2011 | US20110256150 Modulation of Axon Degeneration |
| 10/20/2011 | US20110256147 Diagnostic and treatment methods for cancer based on immune inhibitors |
| 10/20/2011 | US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES |
| 10/20/2011 | US20110256129 Apoptosis promoters |
| 10/20/2011 | US20110256128 Triazole compounds as ksp inhibitors |
| 10/20/2011 | US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma |
| 10/20/2011 | US20110256119 Novel uses of grs proteins or fragments thereof |
| 10/20/2011 | US20110256118 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| 10/20/2011 | US20110256117 Manufacturing and use of composite scaffolds |
| 10/20/2011 | US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds |
| 10/20/2011 | US20110256104 Complexing agents for compositions containing inclusion complexes |
| 10/20/2011 | US20110256100 Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signaling |
| 10/20/2011 | US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle |
| 10/20/2011 | US20110256096 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases |
| 10/20/2011 | US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity |
| 10/20/2011 | US20110256092 Quinoline derivatives for modulating dna methylation |